share_log

Ensysce Biosciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lincoln Park Capital Fund, LLC(3.792%),Lincoln Park Capital, LLC(3.792%), etc.

Ensysce Biosciences | SC 13G/A:超過5%持股股東披露文件(修正)-Lincoln Park Capital Fund, LLC(3.792%),Lincoln Park Capital, LLC(3.792%)等

SEC announcement ·  02/14 16:39
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息